Clinical Trial

OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction

Study acronym: OPTIMISER
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the OPTIMISER Registry is to prospectively and retrospectively collect baseline, clinical and procedural data in patients who present with AMI and are treated with PCI as well as prospectively collect the clinical outcome data. Outcomes will be compared in different clinical subgroups. The impact of PCI in AMI in general as well as cardiovascular outcomes after AMI will be assessed.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-07-25; most recent amendment 2023-10-04.
Trial Details
NCT Number NCT04988672
Lead Sponsor Luzerner Kantonsspital
Conditions Myocardial Infarction, Myocardial Ischemia, STEMI, NSTEMI
Enrollment 4,000 participants
Start Date 2021-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-10-06